Pricing Log in Create free account

BioAtla, Inc. (BCAB) vs KALA BIO, Inc. (KALA)

BioAtla, Inc. and KALA BIO, Inc. are both Biotechnology companies. BioAtla, Inc. and KALA BIO, Inc. are of similar size ($3.0M and $2.9M). BioAtla, Inc. grew revenue faster over the last twelve months: 574.7% against −50.5%. KALA BIO, Inc. has the higher net margin (0.00% vs −177.2%) and the lower return on invested capital (−722.7% vs 0.00%). Across the 15 metrics below, BioAtla, Inc. leads on 8 and KALA BIO, Inc. on 7.

Valuation

Metric BCAB KALA Biotechnology median
P/E n/m n/m 10.60
P/S 0.19 0.52 9.40
P/B n/m 0.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.69 8.04 9.02
Earnings yield (1,272.50%) (31,890.31%) (32.88%)
Free cash flow yield (709.98%) (667.16%) (23.13%)

Profitability

Metric BCAB KALA Biotechnology median
Gross margin 95.44% 0.00% 68.51%
Operating margin (180.99%) 0.00% 0.00%
Net margin (177.21%) 0.00% 0.00%
Free cash flow margin (132.29%) 0.00% 0.00%
Return on equity 118.74% (345.32%) (51.96%)
Return on assets (171.72%) (43.23%) (46.06%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric BCAB KALA Biotechnology median
Revenue growth (TTM) 574.65% (50.54%) 6.76%
EPS growth (last fiscal year) 29.86% 67.39% 29.88%
Revenue growth, 5-year CAGR (28.40%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCAB KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 6.88 4.97
Net debt to EBITDA 0.12 0.19 1.01

Dividend

Metric BCAB KALA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCAB KALA Biotechnology median
Market cap 2.89m 2.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack